These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 39177014

  • 1. LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p/SEMA3A axis.
    Qin SY, Li B, Liu JM, Lv QL, Zeng XL.
    Kaohsiung J Med Sci; 2024 Oct; 40(10):877-889. PubMed ID: 39177014
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
    Li H, Jiang J.
    J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
    [Abstract] [Full Text] [Related]

  • 5. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J, Zhang Y, Wu J, Liu X, Li L, Zhang J.
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LncRNA PCBP1-AS1 suppresses cell growth in oral squamous cell carcinoma by targeting miR-34c-5p/ZFP36 axis.
    Shafiee Allaf O, Li W, Zeng C, Li P, Zhang Y, Xu Y, Bao B.
    Cell Mol Biol (Noisy-le-grand); 2024 Oct 08; 70(9):99-105. PubMed ID: 39380272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2.
    Ye J, He H, Chen S, Ren Y, Guo W, Jin Z.
    Int J Clin Oncol; 2022 Dec 08; 27(12):1891-1903. PubMed ID: 36269529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C, Li Q, Cai Y, He Y, Lan X, Wang W, Liu J, Wang S, Zhu G, Fan J, Zhou Y, Sun R.
    Cancer Gene Ther; 2016 Sep 08; 23(9):295-302. PubMed ID: 27492854
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M, Ning J, Li Z, Fei Q, Zhao C, Ge Y, Wang L.
    Biomed Pharmacother; 2019 Oct 08; 118():109259. PubMed ID: 31369989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, Chen T, Niu Y, Tu K, Liu Q.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):194. PubMed ID: 31088485
    [Abstract] [Full Text] [Related]

  • 18. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY, Weng SM, Hsiao JR, Wu YY, Wu JE, Tung CH, Shen WL, Sun SF, Huang WT, Lin CY, Chen SH, Hong TM, Chen YL, Chang JY.
    J Exp Clin Cancer Res; 2023 Feb 03; 42(1):40. PubMed ID: 36737832
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.